nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A1 adenosine receptors and their ligands: overview and recent developments
|
Müller, Christa E |
|
2001 |
56 |
1-2 |
p. 77-80 4 p. |
artikel |
2 |
Allosteric modulation of G protein-coupled receptors
|
IJzerman, Ad |
|
2001 |
56 |
1-2 |
p. 67-70 4 p. |
artikel |
3 |
Analogues of polyamine alkaloids and their synthetic advantages
|
Li, Yi |
|
2001 |
56 |
1-2 |
p. 127-131 5 p. |
artikel |
4 |
A new class of cytotoxic DNA minor groove binders: α-halogenoacrylic derivatives of pyrrolecarbamoyl oligomers
|
Cozzi, Paolo |
|
2001 |
56 |
1-2 |
p. 57-65 9 p. |
artikel |
5 |
Applications of NMR screening in the pharmaceutical industry
|
Shapiro, Michael |
|
2001 |
56 |
1-2 |
p. 141-143 3 p. |
artikel |
6 |
Binding of polyamine-containing toxins in the vestibule of the nicotinic acetylcholine receptor ion channel
|
Bixel, M.Gabriele |
|
2001 |
56 |
1-2 |
p. 133-135 3 p. |
artikel |
7 |
Characterisation of inter- and intra-molecular interactions of the dengue virus RNA dependent RNA polymerase as potential drug targets
|
Vasudevan, Subhash G. |
|
2001 |
56 |
1-2 |
p. 33-36 4 p. |
artikel |
8 |
Discovery and characterization of non-competitive antagonists of group I metabotropic glutamate receptors
|
Gasparini, Fabrizio |
|
2001 |
56 |
1-2 |
p. 95-99 5 p. |
artikel |
9 |
Discovery of gemifloxacin (Factive, LB20304a): a quinolone of new a generation
|
Hong, Chang Yong |
|
2001 |
56 |
1-2 |
p. 41-44 4 p. |
artikel |
10 |
Disease-modifying anti-osteoarthritic drugs: current therapies and new prospects around protease inhibition
|
De Nanteuil, Guillaume |
|
2001 |
56 |
1-2 |
p. 107-112 6 p. |
artikel |
11 |
Ligands for expression cloning and isolation of GABAB receptors
|
Froestl, Wolfgang |
|
2001 |
56 |
1-2 |
p. 101-105 5 p. |
artikel |
12 |
Lipoprotein-associated PLA2 inhibition — a novel, non-lipid lowering strategy for atherosclerosis therapy
|
Leach, Colin A |
|
2001 |
56 |
1-2 |
p. 45-50 6 p. |
artikel |
13 |
Metabotropic glutamate receptors: structure and new subtype-selective ligands
|
Pellicciari, Roberto |
|
2001 |
56 |
1-2 |
p. 91-94 4 p. |
artikel |
14 |
Microbial fermentation-derived inhibitors of efflux-pump-mediated drug resistance
|
Lee, May D. |
|
2001 |
56 |
1-2 |
p. 81-85 5 p. |
artikel |
15 |
Molecular diversity: how we measure it? Has it lived up to its promise?
|
Martin, Yvonne C. |
|
2001 |
56 |
1-2 |
p. 137-139 3 p. |
artikel |
16 |
New developments in anti-HIV chemotherapy
|
De Clercq, Erik |
|
2001 |
56 |
1-2 |
p. 3-12 10 p. |
artikel |
17 |
[No title]
|
Ronsisvalle, Giuseppe |
|
2001 |
56 |
1-2 |
p. 1- 1 p. |
artikel |
18 |
Novel bone antiresorptive agents that selectively inhibit the osteoclast V-H+-ATPase
|
Farina, Carlo |
|
2001 |
56 |
1-2 |
p. 113-116 4 p. |
artikel |
19 |
Physicochemical properties in pharmacokinetic lead optimization
|
Krämer, Stefanie D. |
|
2001 |
56 |
1-2 |
p. 145-148 4 p. |
artikel |
20 |
Piperidine renin inhibitors: from leads to drug candidates
|
Märki, H.P. |
|
2001 |
56 |
1-2 |
p. 21-27 7 p. |
artikel |
21 |
Prediction of drug toxicity
|
Cronin, Mark T.D. |
|
2001 |
56 |
1-2 |
p. 149-151 3 p. |
artikel |
22 |
Recent advances in the field of quinolones
|
Takemura, Makoto |
|
2001 |
56 |
1-2 |
p. 37-40 4 p. |
artikel |
23 |
Selective adenosine A2A receptor antagonists
|
Ongini, Ennio |
|
2001 |
56 |
1-2 |
p. 87-90 4 p. |
artikel |
24 |
Selective δ opioid receptor agonists for inflammatory and neuropathic pain
|
Dondio, Giulio |
|
2001 |
56 |
1-2 |
p. 117-119 3 p. |
artikel |
25 |
Specific κ opioid receptor agonists
|
Ronsisvalle, Giuseppe |
|
2001 |
56 |
1-2 |
p. 121-125 5 p. |
artikel |
26 |
Structurally related nucleotides as selective agonists and antagonists at P2Y1 receptors
|
Jacobson, Kenneth A. |
|
2001 |
56 |
1-2 |
p. 71-75 5 p. |
artikel |
27 |
Structure-based design of non-peptide HIV protease inhibitors
|
Ghosh, Arun K. |
|
2001 |
56 |
1-2 |
p. 29-32 4 p. |
artikel |
28 |
The 4-anilinoquinazoline class of inhibitors of the erbB family of receptor tyrosine kinases
|
Denny, William A. |
|
2001 |
56 |
1-2 |
p. 51-56 6 p. |
artikel |
29 |
The continuing evolution of the drug discovery process in the pharmaceutical industry
|
Ratti, Emiliangelo |
|
2001 |
56 |
1-2 |
p. 13-19 7 p. |
artikel |